FOR IMMEDIATE RELEASE
Fort Lauderdale, FL, May 07, 2018 -- OmniComm Systems, Inc. (OTCQX: OMCM), a leading global provider of clinical data management technology, today announced the launch of OmniComm AutoEncoder, a user-friendly tool for coding clinical data against medical dictionaries. OmniComm will showcase and demonstrate AutoEncoder at industry events around the globe, including Innovation Forum Europe, June 7-8 in Bonn, DIA China in Beijing on May 23-25, and DIA 2018 in Boston on June 24-28.
“We have taken the opportunity to build a state-of-the-art coding tool from scratch,” said Keith Howells, OmniComm’s chief technology officer. “It has sophisticated algorithms, including language-sensitive search capabilities, and it features a fresh, intuitive and responsive user interface. Coding professionals are going to feel really at home with this product.”
Coding is a unique and necessary process required by regulators during clinical trials or when monitoring the safety of approved products. Regulatory agencies require that adverse events be coded against the MedDRA dictionary, and that medications be coded against the WHO Drug dictionary. The coding process is performed by specialist medical professionals, who must ensure consistent and accurate decisions based on the content of the source term, any relevant related data, and prior decisions for the trial or drug project.
The OmniComm AutoEncoder provides a modern and sophisticated tool for performing these coding activities. Out of the box, AutoEncoder is fully integrated with OmniComm’s TrialMaster® product for Electronic Data Capture, and its open interfaces also allow for integration with any third-party EDC or safety reporting system.
“We are confident that our cutting-edge coding solution will be well received by the industry,” said Stephen Johnson, president and CEO of OmniComm. “AutoEncoder deploys the latest in technology and intuitive design. We’ve leveraged our previous 10 years of experience offering coding solutions and aligned this new technology to match the changing industry regulations. The result is a functionally rich, easy-to-use, innovative solution that is fully integrated with our TrialMaster EDC solution and easily integrated with third-party EDC and safety systems.”
About OmniComm Systems, Inc.
OmniComm Systems provides a role in enhancing patient lives by shortening time to market of essential life-saving treatments. OmniComm Systems is dedicated to providing the latest eClinical technology enabling the world’s life science organizations to maximize the value of their clinical research investments. OmniComm’s solutions provide better trial oversight and study delivery, connecting patients to better healthcare. OmniComm provides comprehensive solutions for clinical research with an extensive global experience from more than 6,000 clinical trials. Please visit www.omnicomm.com for more information.
Trademarks
OmniComm, TrialMaster and TrialOne are registered trademarks of OmniComm Systems, Inc. Other names may be trademarks of their respective owners.
Contact Info Kuno van der Post OmniComm Systems, Inc. +1.954.473.1254 [email protected]


Supermicro Forecasts Strong Q4 Revenue Growth as AI Server Demand Surges
Meta Plans $13B AI Data Center Financing in Texas Amid Surging Big Tech Investment
Agentic AI Boom to Drive Massive Growth in CPU Market, UBS Says
BHP Attracts AI-Focused Investors as Copper Demand Surges
AMD Q1 Earnings Surge on AI Demand, Stock Jumps After Strong Guidance
Regis Resources and Vault Minerals to Merge in $10.7B Gold Deal
Lufthansa Q1 Loss Narrows as Strong Summer Travel Demand Boosts Outlook
Hugo Boss Beats Q1 Profit Expectations Despite Market Headwinds
GameStop Proposes $56 Billion eBay Acquisition in Bold Strategic Move
Anthropic’s $1.5B AI Venture with Wall Street Firms Targets Private Equity Market
Middle East Conflict Impacts Australia and New Zealand Businesses
Strategy Hints at Bitcoin Sales to Cover Dividends After Massive Q1 Loss
Infineon Raises 2026 Outlook as AI Data Center Chip Demand Surges
Samsung Appoints New TV Business Head Amid Rising Competition from Chinese Rivals
Rivian Hints at New R2 Variants as Production Ramps Up Ahead of 2027 Launch
NAB First-Half Earnings Miss Forecasts Amid Rising Global Risks
Philips Reaffirms 2026 Outlook After Strong Q1 Sales and Margin Beat 



